Genome sequencing: parkinsonics – 16 times cheaper
Google Founder Donates $138 Million to Parkinsonism Research
Brin decided to donate $138 million to stimulate the search for new drugs for the treatment of Parkinsonism. Currently, the relevant research is being conducted by pharmaceutical giants Pfizer and GlaxoSmithKline.
The funds allocated by the businessman will help create a database that will include the hereditary information of seven thousand patients with Parkinsonism. These pharmaceutical companies pin their hopes for drug development on these genetic studies.
As previously reported, the sequencing of the genomes of patients with Parkinson's disease will be handled by the company 23andMe, co-owned by Brin's wife Anna Wojcicki.
Unlike ordinary clients, the study participants will pay only $25, not $399, for the genome decoding.
In September 2008, Brin was found to have a G2019S mutation in the LRRK2 gene, the presence of which is associated with a significant risk of developing Parkinson's disease. The G2019S mutation was also detected in the mother of the Google founder, who suffers from this disease.
Portal "Eternal youth" http://vechnayamolodost.ru16.05.2012